Olema Pharmaceuticals Shares Trading Higher; Stock Reacts To Roche lidERA Phase 3 Results Demonstrating Superiority Over Aromatase Inhibitors In Early-Breast Cancer, De-Risking SERD Class Development
Author: Benzinga Newsdesk | November 18, 2025 09:00am